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ABSTRACT
Objectives The aim of the study was to investigate the 
spatial and temporal relationships between the prevalence 
of COVID-19 symptoms in the community- level and area- 
level social deprivation.
Design Spatial mapping, generalised linear models, using 
time as a factor and spatial- lag models were used to 
explore the relationship between self- reported COVID-19 
symptom prevalence as recorded through two smartphone 
symptom tracker apps and a range of socioeconomic 
factors using a repeated cross- sectional study design.
Setting In the community in Northern Ireland, UK. The 
analysis period included the earliest stages of non- 
pharmaceutical interventions and societal restrictions or 
‘lockdown’ in 2020.
Participants Users of two smartphone symptom tracker 
apps recording self- reported health information who 
recorded their location as Northern Ireland, UK.
Primary outcome measures Population standardised 
self- reported COVID-19 symptoms and correlation 
between population standardised self- reported COVID-19 
symptoms and area- level characteristics from measures 
of multiple deprivation including employment levels and 
population housing density, derived as the mean number 
of residents per household for each census super output 
area.
Results Higher self- reported prevalence of COVID-19 
symptoms was associated with the most deprived 
areas (p<0.001) and with those areas with the lowest 
employment levels (p<0.001). Higher rates of self- reported 
COVID-19 symptoms within the age groups, 18–24 
and 25–34 years were found within the most deprived 
areas during the earliest stages of non- pharmaceutical 
interventions and societal restrictions (‘lockdown’).
Conclusions Through spatial regression of self- reporting 
COVID-19 smartphone data in the community, this 
research shows how a lens of social deprivation can 
deepen our understanding of COVID-19 transmission and 
prevention. Our findings indicate that social inequality, as 
measured by area- level deprivation, is associated with 
disparities in potential COVID-19 infection, with higher 
prevalence of self- reported COVID-19 symptoms in urban 
areas associated with area- level social deprivation, 
housing density and age.
INTRODUCTION
Measuring and managing transmission of the 
novel SARS- CoV-2 virus has presented public 
health authorities and policy- makers with 
considerable challenges during the evolution 
of the COVID-19 pandemic.1 The variety of 
approaches adopted by different countries for 
monitoring the spread of the virus, included 
spatiotemporal epidemiology, contagion 
risk models and monitoring platforms,2–5 to 
inform their policy responses. Measurement 
of the number of cases is key to monitoring 
transmission, risk assessment and evaluating 
the effectiveness of non- pharmaceutical soci-
etal interventions. National agencies record 
data on numbers of COVID-19 positive tests, 
hospital admissions and deaths, but these are 
Strengths and limitations of this study
 ► The geographical spread of the self- reporting partic-
ipants using the smartphone apps was investigated 
through spatial mapping and regression using time 
as a factor.
 ► The use of two apps from different smartphone app 
providers enabled a broad sampling of the general 
population using a repeated cross- sectional study 
design.
 ► The predicted variable in the study is the reporting of 
COVID-19 symptoms rather than true disease prev-
alence and therefore caution must be exercised in 
interpreting the results.
 ► Nevertheless, the results may inform the search for 
effective interventions to reduce health inequal-
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biased towards the higher parts of the epidemiological 
pyramid,6 representing mainly people with more severe 
disease and timely access to testing. The challenge during 
the COVID-19 pandemic has been recording those in 
the community with mild symptoms who may not seek 
care or be able to access testing. Moreover, the number 
of infected people in the community depends on indi-
vidual and social behaviours and these data have been 
more difficult to record. The introduction of COVID-19 
symptom trackers as free smartphone apps (launched in 
UK 24 March 2020 and US 29 March 2020) provided a 
way to track in real time how the virus might be trans-
mitting by recording self- reported health information 
from both asymptomatic and symptomatic individuals 
on a daily basis.7–10 At this stage in the pandemic, during 
the earliest stages of non- pharmaceutical interventions, 
viral or other positive testing methods were not widely 
available.11 However, the COVID-19 symptom trackers 
provided a way to record self- reported health information 
from both non- symptomatic and symptomatic individuals 
in the community.
The importance of the link between health and place 
is widely recognised.12 Health inequalities are defined as 
differences in health across the population, and between 
different groups within society.13 An interplay of factors at 
multiple levels can influence health inequalities, including 
the physical and socioeconomic environment.14–17 Limita-
tions in data sampling, data collection and analysis tech-
niques have constrained our understanding of the causes 
of these disparities.18 This has hindered the opportunity 
to provide evidence for effective interventions to reduce 
these disparities and improve overall health outcomes. 
Health inequalities have been documented between 
population groups across socioeconomic status and depri-
vation, vulnerable groups of society or ‘inclusion health’ 
groups and geography.13 The main driver for these differ-
ences is contact networks which arise as a function of social 
behaviour (culture) and urban and rural geographies. It 
is now recognised that the COVID-19 crisis has dispropor-
tionately affected certain at- risk communities, based on 
their previous health, socioeconomic position and ethnic 
characteristics.19–25 While most of the clinical research 
has reported on people experiencing severe illness, in 
this research we investigate the spatial and temporal rela-
tionships between the prevalence of COVID-19 symptoms 
in the community and area- level social deprivation using 
a repeated cross- sectional study design.
METHODS
The current study concentrates on the reporting period 
24 March 2020–22 June 2020 at the earliest stages of non- 
pharmaceutical interventions and societal restrictions 
(‘lockdown’), when viral or other positive testing methods 
were not widely available.11 A repeated cross- sectional 
study design using self- reported COVID-19 symptoms 
smartphone apps provided a way to track the spatial and 
temporal spread of the virus through Northern Ireland 
(NI) by self- reported health information from both 
asymptomatic and symptomatic individuals.
In the UK, administrations in England, Scotland, Wales 
and NI have responsibility for public health functions, 
including most aspects of responding to the COVID-19 
pandemic. Our study setting is NI, one of the devolved 
UK nations, with an estimated mid- year population of 
1 893 700 (30 June 2019).26 Two major symptom tracking 
apps were available and used in NI. The UK COVID-19 
symptom tracker was developed by King’s College London 
(KCL) and the health science company ZOE (https:// 
COVID- 19. joinzoe. com/) and is available to download 
throughout the UK.10 The NI Health and Social Care 
(HSC) service launched its own symptom tracker app, 
COVIDCare NI (formerly known as ‘COVID-19 NI’), on 
620April 2020. The COVIDCare NI symptom checker app, 
developed primarily as part of a triage system, provided 
advice for users on whether they should self- isolate and/
or seek medical assistance. The UK KCL ZOE symptom 
tracker app provided data for NI for the current study 
for the period (24 March 2020–22 June 2020) whereas 
the HSC NI Symptom checker feature (COVIDCare NI) 
provided data for the reporting period 6 April 2020–22 
June 2020. Smartphone ownership does not vary signifi-
cantly by urban or rural location in NI and shows a strong 
alignment with UK prevalence.27 In 2019, 76% of adults 
in the UK reported smartphone ownership.28
Data from both smartphone symptom tracking apps 
were generated on a series of 7 and 14 day periods, known 
as sliding windows. Each period contained: (1) total indi-
vidual active users who have used the COVID-19 symptom 
checking/recording features and (2) total individual 
users recording an assessment, with symptoms meeting 
the classic (new continuous cough or high temperature) 
or refined (new continuous cough or high temperature 
or anosmia) Public Health England (PHE) COVID-19 
case definitions.29 There are some differences between 
the two symptom tracker apps especially with the ‘new’ 
PHE definition which included anosmia. These are:1) 
The symptom of anosmia was included in the KCL 
ZOE symptom tracker app from the start but was only 
included later in the presumptive positive definition. In 
this research study, we, therefore, refer to classic (new 
continuous cough or high temperature) or refined symp-
toms (new continuous cough or high temperature or 
anosmia) as defined by PHE; (2) The COVIDcare NI app 
initially included anosmia as a symptom which could only 
be reported if one of the traditional symptoms was also 
present. The definition was changed at the same time as 
the KCL ZOE symptom tracker app refined the symptoms 
in line with PHE guidelines.29 In summary both symptom 
tracker apps provide a cross sectional study but may 
not be sampling the same repeated cross section of the 
population of NI. Therefore, the symptom tracker app 
data sets were not combined in the analysis but instead a 
comparative analysis was provided.
Both tracker apps require recording a location. As the 
period of the analysis coincided with the first societal 
copyright.
 on A













pen: first published as 10.1136/bm




3McKinley JM, et al. BMJ Open 2021;11:e048333. doi:10.1136/bmjopen-2020-048333
Open access
restrictions (‘lockdown’) in NI, it is reasonable to assume 
that for most people this would have been their home 
location. The KCL ZOE symptom tracker app report is 
linked to one distinct individual record. The COVIDcare 
NI app records events without specific individuals. The 
authors introduced a pseudo- individual marker based on 
a combination of individual factors (handset used, age, 
gender) which proved to be very effective in providing 
distinctive records. Therefore, in the current study we 
assume that for both apps a COVID- symptomatic indi-
vidual has been included once. For this research study, 
both symptom tracker app datasets were analysed at 
super output area (SOA) level. The KCL ZOE tracker 
app generates data geocoded to SOAs, while in the case 
of COVIDCare NI, data were converted from postal code 
to SOAs by the authors. Data containing invalid post-
codes or postcodes outside of NI were removed during 
this postprocessing. There are 890 SOA administrative 
areas across NI.30 When the numbers of users or those 
reporting symptoms (from either app) were too small in 
any SOA (n≤5) these small cell counts were suppressed to 
avoid disclosure risk. By ‘reporting symptoms’ we mean 
that, on any given date, symptoms would have satisfied 
the PHE case definition.29
Area- level deprivation was characterised using the 
orthern Ireland Multiple Deprivation Measures 2017 
(NIMDM) provided by the Northern Ireland Statistics and 
Research Agency (NISRA; figure 1).30 The NIMDMs are 
derived from the 2011 census and were made available by 
the NISRA in 2017. The 2011 census is currently the most 
comprehensive population census for NI. Results for 
the next census are not yet available31 as it took place in 
March 2021. The NIMDMs provide information on seven 
individual domains of deprivation and an overall score 
Figure 1 Northern Ireland Multiple Deprivation Measures 2017 (NIMDM) provided by the Northern Ireland Statistics and 
Research Agency30 including information on overall social deprivation MDMs ranking (A) for NI and (B) for Belfast urban area. 
Low ranking indicates highest deprivation. MDMs, Multiple Deprivation Measures; NI, Northern Ireland.
Figure 2 Smartphone symptom tracker app user demographic profile compared with the population profile of NI. Self- 
reporting COVID-19 symptom data provided by the KCl ZOE symptom tracker app data for NI (reporting period 24 March 2020–
22 June 2020) and COVIDCare NI symptom checker feature, (reporting period 6 April–22 June 2020). NI, Northern Ireland.
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for relative social deprivation, comparable to the Index of 
Multiple Deprivation in England.32 33 The ranking scale is 
from 1 (most deprived) to 890 (least deprived). Popula-
tion household density was used as a further explanatory 
variable to investigate the relationship with self- reported 
COVID-1931 and was derived as the number of residents 
divided by number of households for each SOA.
Regression analysis
The reporting period 6 April 2020–30 May 2020 was 
used for regression analysis, to provide a repeated cross- 
sectional study. KCL ZOE symptom tracker app data for 
NI with revised PHE case definitions and COVIDCare 
NI, based on a repeated 14 day sliding window (resulting 
in a 1- week overlap of data), attributed to the last day of 
the period, were used for regression analysis. The 7- day 
sliding window data were not used due to low number 
issues for some SOAs. For both COVID-19 self- reporting 
symptom mobile platforms, the data were analysed in the 
form of:
 ► Rates calculated as the proportion of active users 
reporting symptoms for each SOA that occurred in 
the defined periods of time, standardised according 
to the population of each SOA. This allowed compar-
ison of a repeated cross- sectional study of self- reported 
prevalence of COVID-19 in terms of active app users 
reporting PHE case definition symptoms.
 ► Age- standardised rates based on the 2011 Census 
population of NI.26 The age brackets used based on 
2011 Census population data (as the most compre-
hensive age band data available) comprised <18, 
18–24, 25–34, 35–49, 50–65 and >65 years.
Generalised regression models (with log link) were 
fitted between the dependent variable ‘population stand-
ardised self- reported COVID-19 symptoms’ and time as 
a factor. The independent variables included area- level 
deprivation indices using overall Multiple Depriva-
tion Measures (MDM), individual deprivation domains 
(adjusting p values for multiple comparisons using the 
Bonferroni correction) and population household 
density. All regression analysis was conducted using glm 
R package and R V.4.0.0. To account for spatial autocor-
relation the Moran’s I statistic and a spatial lag model, 
using spatialreg R package, were used to test the residuals 
computed from the regression models.34 35 Where the 
Moran’s I for the residuals was found to be significantly 
different from random, the generalised linear model 
regression results were compared with a spatial lag model 
and the model fit compared using an Akaike information 
criterion.
Patient and public involvement
No patients were involved.
RESULTS
The smartphone symptom tracker apps user demo-
graphic profile is most comparable with the population 
profile of NI for the age groups 18–24 years and 50–64 
years and shows a higher percentage of users fall within 
the age groups 25–34 and 35–49 years relative to the 
other age groups (figure 2). The self- reporting COVID-19 
symptom data represent a time series of the prevalence 
of self- reported symptoms. The earlier release date of 
the UK KCL ZOE symptom tracker app, compared with 
the COVIDCare NI app, allowed analysis of COVID-19 
self- reporting symptom data at the earliest stages of 
non- pharmaceutical interventions and societal restric-
tions (‘lockdown’) in NI (14 day window data from 30 
March 2020). An increase in active users of the KCL ZOE 
tracker App reporting COVID-19 symptoms was observed 
between 30 March 2020 and 6 April 2020, followed by a 
sharp decrease after 6 April 2020 (figure 3A). The COVID-
Care NI app shows a decrease in active users reporting 
COVID-19 symptoms from the start of reporting period 
20 April 2020 until 22 June 2020. However, there was an 
Figure 3 (A) comparison of percentage of users self- 
reporting COVID-19 symptom data (using data from table 1) 
as provided by the KCl ZOE symptom tracker app data for NI 
(reporting period 24 March 2020–22 June 2020), COVIDCare 
NI symptom checker feature, (reporting period 6 April 2020–
22 June 2020) and (B) laboratory confirmed COVID-19 cases. 
The dates correspond to the end date of 14- day symptom 
reporting sliding window. (B) laboratory confirmed COVID-19 
cases based on published data HSC NI public health agency 
reports.11 HSC, health and social care; NI, Northern Ireland; 
PHE, Public Health England.
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increase in the percentage of COVIDCare NI app users 
reporting PHE symptoms for the time period 30 May 2020 
to 22 June 2020. Although the overall number of users 
for both apps has decreased by this time, the increase 
percentage of COVIDCare NI app users reporting symp-
toms may reflect the NI Public Health Agency messaging 
to use the COVIDCare NI app as a triage system to 
provide advice for symptoms on whether they should self- 
isolate and/or seek medical assistance. Both apps show 
an overall decrease in reported COVID-19 symptoms 
over time which mirrors the reported peak and subse-
quent decline in laboratory confirmed COVID-19 cases 
(figure 3B).11 Although the overall rate (per 100 000 
population) of self- reported symptoms is comparable, 
the geographical coverage varies across the time periods 
(figure 4A,B). The spatial maps (figure 4A,B) indicate 
that KCL ZOE symptom tracker app users were located 
more frequently in high population areas including 
Belfast, whereas coverage for the COVIDCare NI app was 
more even across NI.
Regression analysis revealed a statistically significant 
negative correlation between active users of both mobile 
platforms reporting symptoms and area- level deprivation 
(MDM; p<0.001; table 1). These findings indicate that 
throughout the reporting period, from initial lockdown 
when restrictions were most stringent, the most deprived 
SOAs (lowest social deprivation rankings) were associ-
ated with higher population standardised prevalence 
rates of self- reported COVID-19 symptoms. A statistically 
significant negative correlation was found between users 
reporting COVID-19 symptoms and the area- level depri-
vation measures of employment (p<0.001) and living 
environment (p=0.01) using data from both mobile plat-
forms, (online supplemental table 1).
Using the mean number of residents per household 
for each SOA as a proxy for population housing density 
and time as a factor, a statistically significant negative 
correlation, was found between prevalence rates of self- 
reported COVID-19 symptoms and mean number of 
residents per household for both tracker apps (online 
supplemental table 2). The findings indicate that higher 
self- reported prevalence rates are associated with SOAs 
that have a lower mean number of residents per house-
hold. This seems counterintuitive with the expectation 
that higher density housing would increase the risk of 
transmission. As urban areas have a greater proportion 
of higher density housing, an analysis was carried out for 
the Belfast urban area, the capital city of NI, UK. The 
Belfast urban area comprises 150 SOAs and a population 
of 287, 535 (as defined by the local government districts 
identifier31). For Belfast, a statistically significant nega-
tive correlation was found between self- reported preva-
lence rates and social deprivation (MDM; p<0.001) for 
both Symptom Tracker apps (online supplemental table 
3). The findings for the urban area of Belfast are consis-
tent with that for NI and indicate that during lockdown 
restrictions, the most deprived SOAs were associated with 
higher population standardised prevalence rates of self- 
reported COVID-19 symptoms. However, the relationship 
between population standardised prevalence rates of self- 
reported COVID-19 symptoms for Belfast in relation to 
housing density is quite different from that observed for 
overall NI. A positive relationship is observed indicating 
higher population standardised prevalence rates of self- 
reported COVID-19 symptoms with higher numbers of 
residents per household (p<0.001; online supplemental 
table 3). The findings from the current study indicate 
that higher self- reported prevalence rates are associated 
with SOAs that have a higher mean number of residents 
per household suggesting that higher density housing in 
urban areas increases the risk of transmission.
The relationship between self- reported prevalence rates 
of COVID-19 symptoms and the measures of area- level 
deprivation was explored using age standardised rates of 
self- reported COVID-19 symptom data using COVIDCare 
NI for two 14- day time periods (ending 20 April 2020 and 
11 May 2020) as these time periods provided sufficient 
age standardised data within all age brackets (online 
Figure 4 Maps of COVID-19 symptom data for the reporting period ending 20 April 2020, provided by two sources: (A) 
KCl ZOE symptom tracker app data for new PHE symptoms for Northern Ireland (reported symptoms in 592 SOAs) and (B) 
COVIDCare NI symptom checker feature (reported symptoms in 758 SOAs). The date 20 April corresponds to the end date of a 
14- day symptom reporting sliding window. Self- reported prevalence rates are standardised for 100 000 population. NI, Northern 
Ireland; PHE, Public Health England; SOA, super output area.
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supplemental table 4). A statistically significant negative 
correlation was found between prevalence rates of self- 
reported COVID-19 symptoms and area- level deprivation 
for the age groups 18–24 years and 25–34 years (p<0.001 
for both time periods for age group 25–34 years). In 
contrast, a statistically significant positive correlation with 
area- level deprivation was found for the age groups 50–64 
years and >65 years (online supplemental table 4). The 
results of this current study reveal a statistically signifi-
cant positive relationship between self- reported preva-
lence rates of COVID-19 symptoms and mean number 
of residents per household (housing density) for the age 
groups<18 years (for both time periods), 35–49 years 
and 50–64 years (shown for time period ending 11 May; 
online supplemental table 4). In contrast, a statistically 
significant negative correlation with population housing 
density was found for the age group 25–34 years (p<0.001 
for both time periods for age group 25–34 years). A statis-
tically significant negative correlation was found between 
self- reported prevalence rates of COVID-19 symptoms 
and overall social deprivation for the age group 25–34 
(p<0.001 for both time periods for age group 25–34 
years).
DISCUSSION
Our research has shown how a lens of area- level depriva-
tion can deepen our understanding of COVID-19 trans-
mission and prevention. Our findings indicate that social 
inequality, as measured by area- level deprivation, is asso-
ciated with disparities in potential COVID-19 infection, 
with higher prevalence of self- reported COVID-19 symp-
toms in urban areas associated with area- level deprivation, 
housing density and age. The findings from the current 
study provide evidence for the disproportionate adverse 
effects of the interventions of societal restrictions (eg, 
‘lockdown’) on areas of greater deprivation and in partic-
ular the impact of higher prevalence of self- reported 
COVID-19 symptoms in younger populations who have a 
higher likelihood of living in higher density housing types 
in urban areas.
There has been much debate and research on 
the increased risk for the socially vulnerable during 
natural and human disasters, including the COVID-19 
pandemic.36–38 The pandemic has magnified the heteroge-
neity in society’s health burden with a disproportionately 
higher impact on socially vulnerable communities.20–25 
These socioeconomic inequalities are linked directly to 
Table 1 Regression analysis (GLM log link), with time as a factor, of COVID-19 symptom mobile data platforms provided by 
two sources: KCL ZOE symptom tracker app data for NI and HSC NI Symptom checker feature (COVIDCare NI) and covariate 
area- level deprivation (MDM)
Date Estimate Std. error T value Pr(>|t|) Signif. codes
KCL ZOE
Intercept 3.135 0.0325 96.505 <2.00E-16 <0.001
06 Apr 2020 0.0002 0.0425 0.005 0.99590
13 Apr 2020 0.2441 0.0401 6.084 1.25E-09 <0.001
20 Apr 2020 0.2053 0.0431 4.77 1.89E-06 <0.001
27 Apr 2020 0.1405 0.0467 3.011 0.0026 0.001
04 May 2020 0.1508 0.0468 3.225 0.0013 <0.001
11 May 2020 0.1775 0.0465 3.82 0.0001 <0.001
18 May 2020 0.3503 0.0437 8.019 1.29E-15 <0.001
23 May 2020 0.3422 0.0449 7.627 2.8E-14 <0.001
30 May 2020 0.3662 0.0471 7.78 8.57E-15 <0.001
MDM −0.0022 5.07E-05 −43.457 <2.00E-16 <0.001
COVIDCare NI
Intercept 3.189 0.0327 97.495 <2e-16 <0.001
27 Apr 2020 −0.0138 0.0414 −0.333 0.7391
04 May 2020 −0.0009 0.0421 −0.02 0.9837
11 May 2020 0.0278 0.0424 0.654 0.5128
18 May 2020 0.0450 0.0433 1.038 0.2995
23 May 2020 0.1341 0.0423 3.173 0.0015 0.001
30 May 2020 0.4452 0.0384 11.598 <2e-16 <0.001
MDM −0.0005 0.0004 −11.361 <2e-16 <0.001
The dates shown correspond to the end date of the 14- day symptom reporting sliding window (resulting in a 1- week overlap 
of data).
GLM, generalised linear model; HSC, health and social care; MDM, Multiple Deprivation Measure; NI, Northern Ireland.
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area- level deprivation indices including income, educa-
tion, employment, housing and environment, which 
contribute to greater risk of poor health.39–42 Our study 
has shown the value of using symptom reporting to 
enable a more granular exploration of social depriva-
tion, housing density and age effect. The findings from 
our research reveal that the highest self- reported prev-
alence rates of COVID-19 symptoms were found to be 
associated with the most deprived areas (lowest social 
deprivation rankings) and the most deprived areas with 
lowest ranking for employment. Studies from other coun-
tries based on the same time period (March 2020–July 
2020) concur with these findings in that the impact of the 
SARS- CoV-2 infection was found to be higher (up to three 
times higher on deprived communities.23 Other studies 
indicate a link between deprivation and higher mortality 
rates after infection.24
The findings from our research reveal differing rela-
tionships with the domains of area- level deprivation across 
age groups. Higher self- reported prevalence rates of 
COVID-19 symptoms in the age groups 18–24 and 25oc–
34oc occurred in the most deprived areas. This finding 
suggests that population density may be an important 
factor for these age groups, which may not be the most 
at- risk groups for the consequences of infection, but may 
spread the virus through the community. This research 
indicates that other factors such as area- level deprivation 
are more important for the prevalence rates of COVID-19 
symptoms for the age groups <18 years, 35–49 years and 
50–64 years age group. Incidence across time periods was 
also affected by the average number of people in a house-
hold. The current research suggests that a more in- depth 
analysis by location is required to examine the influence 
of rural and urban geography on the effects of area- level 
deprivation and population housing density on preva-
lence rates of COVID-19 symptoms. The disproportionate 
impact of societal restrictions (including ‘lockdown’) on 
areas of greater deprivation is a cause for concern and 
suggests targeted interventions (increased availability 
and accessibility of testing) are required to mitigate the 
impacts in areas of higher deprivation.
Limitations
Our research dealt with symptom reporting, which is a 
combination of (1) COVID-19- induced symptoms and 
(2) symptoms that are not due to COVID-19. Thus, the 
signal measured includes COVID-19 prevalence but also 
includes false positives. The reader is also reminded that 
the measured signal is a function of: (1) having the requi-
site symptoms, (2) the propensity to report symptoms, 
(3) the likelihood to participate in one or other survey, 
(4) ownership of a smartphone and (5) being part of the 
at- risk population. Census data for other confounders 
including adult obesity and respiratory disease were not 
available at SOA level.
For this research, the estimate of household density 
was derived by using the mean number of residents 
per household for each SOA as a proxy for population 
housing density, as the address of the phone user was 
not identified due to confidentiality issues. This method 
suggests a uniform household size per SOA when it is 
likely to be very heterogeneous. It is acknowledged that 
this is a limitation of the study which may introduce inac-
curacies especially where there is a small population of 
app users in any SOA.
A third limitation is that symptom- based surveil-
lance and the use of self- reported data may give rise to 
collider bias when observational data are recorded from 
non- random samples, involving voluntary participation 
and self- reported symptoms, which may impact the reli-
ability and generalisability of the findings.43 It has been 
suggested that voluntary participants are more likely to 
be highly educated and health conscious and, therefore, 
may differ substantially from the general population. 
Symptom reporting behaviour may also be different 
across socioeconomic groups.44
A fourth potential limitation of the study is that self- 
reporting participants came from within the adult popula-
tion who had access to the use of a smartphone (estimated 
to be 76% of the general NI population). However, the 
use of two forms of smartphone app enabled a broader 
sampling of the general population where the geograph-
ical spread of the self- reporting participants using the 
different smartphone apps was investigated through 
spatial mapping. The greatest geographical coverage was 
reported for the 14 day period ending 20 April 2020 for 
both smartphone apps (self- reporting participants from 
592 SOAs and 758 SOAs for the KCL ZOE and COVID-
Care NI apps, respectively; total 850 SOAs for NI). As 
such, the main period for this analysis was during the first 
UK lockdown, when restrictions were more severe.
CONCLUSIONS
COVID-19 symptom prevalence estimates obtained from 
self- reporting COVID-19 smartphone data were regressed 
on a range of socioeconomic variables in NI. Significant 
associations were found between reported COVID-19 
prevalence and both area- level deprivation and housing 
density in urban areas for a range of age groups. The find-
ings underline that social inequality, as measured by area- 
level deprivation, creates disparities in risk of COVID-19 
infection. Specifically, the results from our research 
indicate a heightening of health inequalities during the 
period of societal restrictions with higher self- reported 
prevalence of COVID-19 symptoms associated with areas 
with the greatest area- level deprivation and the lowest 
deprivation rankings for employment, particularly within 
the age group 18–34. This increased reporting rate in the 
younger population may signal increased prevalence and 
transmission of the virus, which is likely to have a negative 
impact on at- risk communities. These findings, therefore, 
have the potential to inform COVID-19 prevention strat-
egies through targeted messaging to change behaviour 
(‘mask’: ‘face’; ‘space’) to mitigate the disproportionate 
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impact of extended periods of societal restrictions (such 
as ‘lockdown’) in areas of area- level deprivation.
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